RecruitingPhase 3NCT07654374
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Portland, OR · +73 more sites
Obesity clinical trials in Portland, OR
8 recruiting obesity studies with a site in Portland, OR.
RecruitingPhase 3NCT07351045
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Sponsor: Hoffmann-La Roche
Portland, OR · +43 more sites
RecruitingPhase 3NCT07667803
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Sponsor: AstraZeneca
Portland, OR · +55 more sites
RecruitingPhase 3NCT07776509
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Portland, OR · +22 more sites
RecruitingPhase 4NCT06857942
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Sponsor: Eli Lilly and Company
Portland, OR · +38 more sites
RecruitingNot applicableNCT04326192
Brown Adipose Tissue Activation by Spinal Cord Stimulation
Sponsor: Oregon Health and Science University
Portland, OR
RecruitingPhase 3NCT07654361
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Portland, OR · +70 more sites
RecruitingNot applicableNCT06011499
Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVE
Sponsor: OHSU Knight Cancer Institute
Portland, OR
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.